AstraZeneca Enters Pact with Cell Therapy Startup 

AstraZeneca will pay Quell Therapeutics $85 million upfront for it to help develop treatments for autoimmune diseases, and further payments of more than $2 billion for future development and commercial milestones and royalties.

Dassault Systems Outlines Midterm Targets; Names New CEO 

Dassault Systemes forecast double-digit revenue growth and earnings of EUR2.2-EUR2.4 a share in 2028, as the software company named Pascal Daloz as its new CEO effective the beginning of next year.

Meta Reveals Twitter Competitor Planned as Stand-Alone App 

Separately, Chief Executive Mark Zuckerberg criticizes Apple's Vision Pro headset, saying Meta has tried to make products affordable.

GM EV Owners to Tap Tesla's Supercharger Network 

The Detroit automaker said it would adopt Tesla's charge-port hardware on future models.

DocuSign Shares Climb With Turnaround Efforts Under Way 

The e-signature company has cut jobs and changed leadership in response to slower growth.

Carvana Shares Jump More Than 50% as Company's Profit Outlook Improves 

The online used-car retailer says its cost-cutting efforts are taking hold.

Wildfire Smoke Boosts N95 Mask Demand 

Health officials recommended N95 masks to protect against smoke inhalation. 3M, Grainger and Lowe's are responding to the surge.

GameStop's Silence Is No Longer Golden 

Weak results and a surprise CEO firing call for an explanation as Ryan Cohen takes full charge of the company.

Supreme Court Says Jack Daniel's Can Sue Maker of 'Bad Spaniels' Dog Toy 

The Supreme Court said the distiller of Jack Daniel's whiskey could pursue a trademark claim against the maker of Bad Spaniels, a dog toy resembling a famous liquor bottle.

Construction Boom Fuels Surge in Excavator Sales 

Deere, Caterpillar and CNH Industrial are expanding or upgrading their models to meet surging demand for building and infrastructure projects.


(END) Dow Jones Newswires

June 09, 2023 03:15 ET (07:15 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.